Answers are grounded in this paper and cite their sources.
Pahnitoyl-CoA (100 PM), in the presence of albumin (24 mg per ml), inhibited the incorporation of [14C]citrate into fatty acids in a cytosol fraction of chick liver and inhibited the activity of acetyl-CoA carboxylase purified from chick liver.Under similar incubation conditions, pahnitoyl-CoA (ZOO PM) did not inhibit fatty acid synthetase, ATP-citrate lyase, malic enzyme, NADP-linked isocitrate dehydrogenase, pyruvate kinase, or glutamate dehydrogenase.The high concentration of albumin was used to ensure that the free concentration of pahnitoyl-CoA was very low and relatively independent both of the concentration of the enzyme tested and of its aflinity for palmitoyl-CoA.In the presence of 0.26 mg of albumin per ml and 1 fzl~ citrate, 1 PM palmitoyl-CoA inhibited the activity of the partially purified acetyl-CoA carboxylase by about 75%.This inhibition was reversed after 9 min of incubation by increasing the albumin concentration to 11 mg per ml or by increasing the citrate concentration to 6 ells or by adding 10 PM (+) -pahnitoylcamitine.At both high and low albumin concentrations, inhibition by pahnitoyl-CoA was competitive with respect to citrate.Inhibition of acetyl-CoA carboxylase by pahnitoyl-CoA occurred immediately and did not increase with time of incubation.It is concluded that pahnitoyl-CoA inhibition of acetyl-CoA carboxylase is reversible and competitive with citrate and, therefore, may play an important role in the regulation of fatty acid synthesis in vivo.
No takes yet. Share an insight, caveat, or question.
Alan Goodridge (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: